Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
Nikolsky E, Mehran R, Sadeghi HM, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Stone GW. Nikolsky E, et al. Among authors: stone gw. JACC Cardiovasc Interv. 2009 Jul;2(7):624-32. doi: 10.1016/j.jcin.2009.05.004. JACC Cardiovasc Interv. 2009. PMID: 19628185 Free article. Clinical Trial.
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Stone GW, et al. Am J Cardiol. 1996 Jul 1;78(1):19-25. doi: 10.1016/s0002-9149(96)00220-2. Am J Cardiol. 1996. PMID: 8712112 Clinical Trial.
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe JH, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Stone GW, et al. Cathet Cardiovasc Diagn. 1996 Dec;39(4):333-9. doi: 10.1002/(SICI)1097-0304(199612)39:4<333::AID-CCD1>3.0.CO;2-E. Cathet Cardiovasc Diagn. 1996. PMID: 8958418 Clinical Trial.
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW. Stone GW, et al. J Am Coll Cardiol. 1997 Apr;29(5):901-7. doi: 10.1016/s0735-1097(97)00041-7. J Am Coll Cardiol. 1997. PMID: 9120173 Free article. Clinical Trial.
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators.
Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O'Neill WW, Grines CL. Stone GW, et al. J Am Coll Cardiol. 1997 Jun;29(7):1459-67. doi: 10.1016/s0735-1097(97)00088-0. J Am Coll Cardiol. 1997. PMID: 9180105 Free article. Clinical Trial.
1,721 results